![Gary Phillips](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Phillips
Directeur Général chez
SYNTARA LIMITED
Fortune : 40 296 $ au 31/05/2026
Profil
Gary Jonathan Phillips is Chief Executive Officer, Executive Director & MD at Syntara Ltd. since 2013 and a Member of the Australian Institute of Co. Directors.
Former roles include Chief Executive Officer-Hungary at Ciba-Geigy AG from 1992 to 1998, Chief Executive Officer-Pharmaceutical Division at Novartis Australia Pty Ltd., Area Director-Asia at Novartis AG, and Independent Non-Executive Director at Arovella Therapeutics Ltd. from 2022 to 2026.
Education includes an MBA from Henley Business School Ltd. and an undergraduate degree from The University of Nottingham.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/02/2026 | 788 888 ( 0,07 % ) | 40 296 $ | 31/05/2026 |
Postes actifs de Gary Phillips
| Sociétés | Poste | Début |
|---|---|---|
| SYNTARA LIMITED | Directeur Général | 12/03/2013 |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
Anciens postes connus de Gary Phillips
| Sociétés | Poste | Fin |
|---|---|---|
| AROVELLA THERAPEUTICS LIMITED | Directeur/Membre du Conseil | 09/02/2026 |
Ciba-Geigy AG
 Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 01/01/1998 |
| NOVARTIS AG | Corporate Officer/Principal | 31/12/1996 |
Novartis Australia Pty Ltd.
 Novartis Australia Pty Ltd. BiotechnologyHealth Technology Manufactures biological products | Corporate Officer/Principal | - |
Formation de Gary Phillips
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Syntara Ltd.
 Syntara Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and wholesales pharmaceutical products for respiratory disorders | Health Technology |
Henley Business School Ltd.
 Henley Business School Ltd. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Arovella Therapeutics Ltd.
 Arovella Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and distributes medical devices and consumables | Health Technology |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Novartis Australia Pty Ltd.
Novartis Australia Pty Ltd. BiotechnologyHealth Technology Manufactures biological products | Health Technology |
